Injectable nanomaterial-extracellular matrix constructs
US11160906B2 · kind B2 · utility
0Cited by
0References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 21, 2017 |
| Grant date | Nov 2, 2021 |
| Priority date | — |
| Expiry date | Dec 3, 2038 |
Classification
- Technology area (CPC B)Performing Operations; Transporting
- CPC primaryB82Y5/00
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
The present invention provides a series of injectable bionanocomposites that may be delivered via injection to various tissue repair sites including myocardial infarction, intervertebral disc reconstruction, reconstruction of skeletal muscle, and musculoskeletal applications, urinary incontinence, adipose tissue engineering, and orthopedic applications such as osteoporosis, and meniscus and articular cartilage repair.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.